More about
Sotagliflozin
As a class, sodium–glucose transporter 2 inhibitors are novel drugs initially developed for glycemic control in patients with type 2 diabetes.
[Cowie MR, et al. Nat Rev Cardiol. 2020;1a]
As a class, sodium–glucose transporter 2 inhibitors are novel drugs initially developed for glycemic control in patients with type 2 diabetes.
[Cowie MR, et al. Nat Rev Cardiol. 2020;1a]